APTO Kacepetan wutah bathi saben saham ing taun lumaku Aptose

APTO (Aptose Biosciences) - tandha merek perusahaan

Optimized raw material delivery for testing supports the trend shown on the annual EPS change scale. Robotic cell analysis accelerates research, yet the lack of profitability and biopharma volatility create financial risks. This chart illustrates capital volatility, and 74.00 captures the current indicator value, helping to assess the real business value of Aptose Biosciences Inc. (APTO).

APTO - Wutah bathi ing taun lumaku Aptose Biosciences ing rentang 04.07.2022 - 13.04.2025

Rincian metrik komprehensif lan analitis aptose.com (APTO)

- nilai saham lan prakiraan konsensus rega:
Rega bursa Aptose|APTO - Bagan rega target
- data kapitalisasi pasar:
Nilai pasar Aptose Biosciences|APTO - Nilai Perusahaan
- data ekuitas miturut neraca:
Ekuitas saben Saham Aptose Biosciences|APTO - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku aptose.com|APTO - Aset Agregat Perusahaan
- indikator beban utang lan likuiditas:
Utang Agregat marang Ekuitas Aptose Biosciences Inc.|APTO - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal Aptose|APTO - Utang perusahaan|Utang-utang marang nilai buku Aptose Biosciences Inc.|APTO - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Aptose Biosciences|Likuiditas darurat aptose.com
- statistik bathi lan rasio pasar:
APTO - Penghasilan resik|Penghasilan resik sing dikarepake Aptose Biosciences Inc.|APTO - Pangali P/E|Rega marang bathi mangsa ngarep Aptose Biosciences Inc|APTO - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Aptose Biosciences Inc.|APTO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan Aptose Biosciences|APTO - Bathi saben saham sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan aptose.com|APTO - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Aptose Biosciences Inc.
- informasi babagan volume dodolan lan pendapatan:
APTO - Pendapatan lan volume dodolan|Dodolan mangsa ngarep perusahaan Aptose Biosciences Inc|APTO - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Aptose Biosciences Inc.
Analisis dhasar perusahaan:APTO aptose.com
Sampel barang Aptose Biosciences Inc.

To separate fundamental value from speculative noise, it is critical for investors to evaluate real capital efficiency. For Aptose Biosciences Inc. (APTO), which focuses on clinical trials for leukemia therapies, profit is secondary to expansion milestones. By analyzing the annual percentage trend of earnings per share, you can see the calculated change in EPS, reflecting the company's sensitivity to market shocks and borrowing costs.

Pesaing utama

Kacepetan wutah bathi saben saham ing taun lumaku TG Pharma (TGTX)|Wutah bathi saben saham ing taun lumaku Arcellx Inc|Kacepetan wutah bathi saben saham ing taun lumaku Disc Medicine, Inc. IRON|Wutah bathi ing taun lumaku SNDX|Kura Oncology Inc - Wutah bathi saben saham ing taun iki|Wutah bathi ing taun lumaku ADCT (ADC Therapeutics S.A.)|FHTX (Foghorn Therapeutics) - Dinamika bathi saben saham ing taun lumaku|VOR - Wutah bathi saben saham ing taun lumaku|NKTX - Wutah bathi ing taun lumaku|COEP: Wutah bathi ing taun lumaku|ATNM: Wutah bathi resik saben siji saham kanggo taun lumaku|Wutah bathi saben saham ing taun lumaku Estrella Bio|CASI Pharmaceuticals, Inc. (CASI) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi ing taun lumaku MRKR|Wutah bathi saben saham ing taun lumaku INAB (IN8bio, Inc)|Wutah bathi ing taun lumaku ERNA (Eterna Therapeutics, Inc.)|GT Biopharma Inc (GTBP) - Kacepetan wutah bathi saben saham ing taun lumaku|BPTH: Wutah bathi resik saben saham ing taun iki|MEIP - Wutah bathi ing taun lumaku|VINC (Vincerx) - Wutah bathi resik saben saham ing taun iki